This document provides a landscape of 5-dose vial measles (M) and measles-rubella (MR) vaccine use in Africa - In 2020, Africa’s Regional Immunization Technical Advisory Group (RITAG) recommended the use of measles-containing vaccine (MCV) 5-dose vials as part of a broad recovery strategy to raise coverage, reduce wastage, and avoid healthcare worker (HCW) reluctance to open 10-dose vials, especially where session sizes are small - As of September 2022, there are ten countries in Africa using M/MR 5-dose vials for routine immunization (RI): Botswana, Cabo Verde, Comoros, DRC, Equatorial Guinea, Eritrea, Eswatini, Lesotho, Niger, and Sao Tome. Sudan is planning to transition to 5-dose in 2023